SCHEMBL30708166

SCHEMBL30708166

O=c1oc2cc(N3CCNCC3)ccc2cc1-c1cn2cc(F)ccc2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPT P10636 3/20 0.45
LMNA P02545 2/20 0.45
PKM P14618 1/20 0.45
SUV39H2 Q9H5I1 6/20 0.44
POLB P06746 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
TP53 P04637 4/20 0.41
TLR9 Q9NR96 2/20 0.39
TLR7 Q9NYK1 2/20 0.39
ESR1 P03372 1/20 0.38
CASP1 P29466 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
IDO1 P14902 1/20 0.38
TDO2 P48775 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15068501 1.00 NPC1 (0.45) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL15068779 0.89 NPC1 (0.44) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL15069070 0.89 NPC1 (0.47) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL15069225 0.88 SUV39H2 (0.48) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL30708168 0.88 SUV39H2 (0.48) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL27261158 0.87 ALDH1A1 (0.43) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL27261032 0.87 NPC1 (0.48) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL15068751 0.87 NPC1 (0.41) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL15068921 0.86 NPC1 (0.41) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL16669726 0.85 NPC1 (0.45) NPC1RAB9AALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024006287-A2 ANTIVIRAL COMPOUNDS USEFUL AGAINST SARS-COV-2 UNIVERSITY OF KANSAS (US) 2024-01-04 WO claimed
WO-2024006287-A2 ANTIVIRAL COMPOUNDS USEFUL AGAINST SARS-COV-2 UNIVERSITY OF KANSAS (US) 2024-01-04 WO disclosed